{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:51:26Z","timestamp":1768823486643,"version":"3.49.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Child sun protection has recently been linked to the future disappearance of fatal melanoma in adults in successive generations. In the Netherlands, however, mortality rates from melanoma have increased gradually from the 1950s, with some indication of stabilisation since 2010, which may be compatible with a birth cohort effect by sun-protective measures and screening. To study the trajectories ahead a trend analysis was applied. Numbers of people with cutaneous melanoma as underlying cause of death from 1950 to 2018 and population data were derived from Statistics Netherlands. A graphical approach was used to explore trends in mortality by age, calendar period, and cohorts born in the successive periods of 1889 to 1979. Age\u2013period\u2013cohort modelling outcomes and population forecasts provided projections of mortality until 2045. Based on 24,151 cases of melanoma death (13,256 men, 10,895 women), age-standardised mortality rates were similar from 1950 to 1989 for both genders, and increased thereafter more in men. The age-curve patterns changed gradually towards higher death rates at older age, implying the existence of a birth cohort effect. The age\u2013period\u2013cohort models showed an increase in melanoma mortality rates in successive generations. For women, the birth cohort effect plateaued for generations born since the mid-1980s. The projected total mortality number was predicted to rise in the next 3 decades.<\/jats:p>\n            <jats:p>It is concluded that a small future decline of mortality in younger generations can be expected in the Netherlands, but mortality is still rising for the total population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027784","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T13:08:09Z","timestamp":1638536889000},"page":"e27784","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Trends and projections in cutaneous melanoma death in the Netherlands from 1950 to 2045"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6527-7217","authenticated-orcid":false,"given":"Catharina C.","family":"van Niekerk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4974-150X","authenticated-orcid":false,"given":"Hans M.M.","family":"Groenewoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2319-5002","authenticated-orcid":false,"given":"Andr\u00e9 L.M.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.5826\/dpc.0702a01","article-title":"Epidemiological trends in skin cancer","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol Pract Concept"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ejca.2015.01.056","article-title":"The forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populations","volume":"51","author":"Autier","year":"2015","journal-title":"Eur J Cancer"},{"key":"R5-20250504","first-page":"545","article-title":"Mortality trends in cutaneous malignant melanoma in Spain, 1967\u20131986","volume":"2","author":"Poll\u00e1n","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.312.7039.1121","article-title":"Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994","volume":"312","author":"Giles","year":"1996","journal-title":"BMJ"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/1055-9965.EPI-11-0421","article-title":"Age\u2013period\u2013cohort models in cancer surveillance research: ready for prime time?","volume":"20","author":"Rosenberg","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0959-8049(93)90585-4","article-title":"Trends in mortality from malignant cutaneous melanoma in The Netherlands, 1950\u20131988","volume":"29A","author":"Nelemans","year":"1993","journal-title":"Eur J Cancer"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ijc.23118","article-title":"Effect of age, birth cohort and period of death on skin melanoma mortality in Spain, 1975 through 2004","volume":"122","author":"Cayuela","year":"2008","journal-title":"Int J Cancer"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/sim.4780060405","article-title":"Models for temporal variation in cancer rates. I: age\u2013period and age\u2013cohort models","volume":"6","author":"Clayton","year":"1987","journal-title":"Stat Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ije\/14.1.124","article-title":"Using age, period and cohort models to estimate future mortality rates","volume":"14","author":"Osmond","year":"1985","journal-title":"Int J Epidemiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/bjd.16777","article-title":"Is melanoma mortality declining in Spain? Analysis of trends from 1975 to 2016","volume":"179","author":"Cayuela","year":"2018","journal-title":"Br J Dermatol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/CMR.0000000000000609","article-title":"Ultraviolet radiation and cutaneous melanoma: a historical perspective","volume":"30","author":"Autier","year":"2020","journal-title":"Melanoma Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0959-8049(02)00104-1","article-title":"Survival probabilities and hazard functions of malignant melanoma in Germany 1972\u20131996, an analysis of 10433 patients. Evolution of gender differences and malignancy","volume":"38","author":"K\u00f6lmel","year":"2002","journal-title":"Eur J Cancer"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0140-6736(14)61396-9","article-title":"40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971\u20132011: a population-based study","volume":"385","author":"Quaresma","year":"2015","journal-title":"Lancet"},{"key":"R20-20250504","first-page":"591","article-title":"Centers for Disease Control and Prevention (CDC). Vital signs: melanoma incidence and mortality trends and projections \u2013 United States, 1982\u20132030","volume":"64","author":"Guy","year":"2015","journal-title":"MMWR Morb Mortal Weekly Rep"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0969141317734003","article-title":"Observed and expected mortality in the German skin cancer screening pilot project SCREEN","volume":"25","author":"Eisemann","year":"2018","journal-title":"J Med Screen"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1056\/NEJMsb2019760","article-title":"The rapid rise in cutaneous melanoma diagnosis","volume":"384","author":"Welch","year":"2021","journal-title":"N Engl J Med"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"key":"R24-20250504","first-page":"CD011123","article-title":"Systemic treatments for metastatic cutaneous melanoma","volume":"2","author":"Pasquali","year":"2018","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:37:21Z","timestamp":1746333441000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":19,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027784","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,3]]},"assertion":[{"value":"2021-03-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}